| 000 | 01649 a2200577 4500 | ||
|---|---|---|---|
| 005 | 20250513134016.0 | ||
| 264 | 0 | _c19980312 | |
| 008 | 199803s 0 0 eng d | ||
| 022 | _a0004-4172 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPizzolato, G | |
| 245 | 0 | 0 |
_aRandomised, double-blind, placebo-controlled study of pivagabine in neurasthenia. _h[electronic resource] |
| 260 |
_bArzneimittel-Forschung _cNov 1997 |
||
| 300 |
_a1329-31 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeurasthenia _xdrug therapy |
| 650 | 0 | 4 | _aPsychiatric Status Rating Scales |
| 650 | 0 | 4 |
_aPsychotropic Drugs _xadverse effects |
| 650 | 0 | 4 |
_agamma-Aminobutyric Acid _xadverse effects |
| 700 | 1 | _aCagnin, A | |
| 700 | 1 | _aMancia, D | |
| 700 | 1 | _aCaffarra, P | |
| 700 | 1 | _aAvanzi, S | |
| 700 | 1 | _aCopelli, S | |
| 700 | 1 | _aCiappina, C | |
| 700 | 1 | _aLo Presti, F | |
| 700 | 1 | _aSpilimbergo, P G | |
| 700 | 1 | _aD'Antonio, E | |
| 700 | 1 | _aDi Costanzo, E | |
| 700 | 1 | _aMatrango, M | |
| 700 | 1 | _aPastres, P | |
| 700 | 1 | _aUrbani, P P | |
| 700 | 1 | _aSignorino, M | |
| 700 | 1 | _aSimoncelli, M | |
| 700 | 1 | _aProvinciali, L | |
| 700 | 1 | _aRegnicolo, L | |
| 700 | 1 | _aAlbano, C | |
| 700 | 1 | _aRoccatagliata, G | |
| 700 | 1 | _aRubino, V | |
| 700 | 1 | _aCultrera, S | |
| 700 | 1 | _aFracassi, M | |
| 773 | 0 |
_tArzneimittel-Forschung _gvol. 47 _gno. 11A _gp. 1329-31 |
|
| 999 |
_c9419271 _d9419271 |
||